A physiologically-based kinetic model for the prediction of plasma cholesterol concentrations in the mouse

被引:5
|
作者
van de Pas, Niek C. A. [1 ,2 ,3 ]
Woutersen, Ruud A. [1 ,2 ,3 ]
van Ommen, Ben [1 ]
Rietjens, Ivonne M. C. M. [2 ,3 ]
de Graaf, Albert A. [1 ]
机构
[1] Netherlands Org Appl Sci Res TNO, NL-3700 AJ Zeist, Netherlands
[2] Wageningen Univ, Div Toxicol, NL-6703 HE Wageningen, Netherlands
[3] TNO WUR Ctr Innovat Toxicol, NL-6703 HE Wageningen, Netherlands
关键词
Plasma cholesterol; PBK modeling; Knockout mouse strains; LDL cholesterol; HDL cholesterol; DIET-INDUCED HYPERCHOLESTEROLEMIA; CORONARY-HEART-DISEASE; RECEPTOR CLASS-B; E-DEFICIENT MICE; APOLIPOPROTEIN-E; SCAVENGER RECEPTOR; SR-BI; SELECTIVE UPTAKE; FATTY ACID; IN-VIVO;
D O I
10.1016/j.bbalip.2011.02.002
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The LDL cholesterol (LDL-C) and HDL cholesterol (HDL-C) concentrations are determined by the activity of a complex network of reactions in several organs. Physiologically-based kinetic (PBK) computational models can be used to describe these different reactions in an integrated, quantitative manner. A PBK model to predict plasma cholesterol levels in the mouse was developed, validated, and analyzed. Kinetic parameters required for defining the model were obtained using data from published experiments. To construct the model, a set of appropriate submodels was selected from a set of 65,536 submodels differing in the kinetic expressions of the reactions. A submodel was considered appropriate if it had the ability to correctly predict an increased or decreased plasma cholesterol level for a training set of 5 knockout mouse strains. The model thus defined consisted of 8 appropriate submodels and was validated using data from an independent set of 9 knockout mouse strains. The model prediction is the average prediction of 8 appropriate submodels. Remarkably, these submodels had in common that the rate of cholesterol transport from the liver to HDL was not dependent on hepatic cholesterol concentrations. The model appeared able to accurately predict in a quantitative way the plasma cholesterol concentrations of all 14 knockout strains considered, including the frequently used Ldlr-/- and Apoe-/- mouse strains. The model presented is a useful tool to predict the effect of knocking out genes that act in important steps in cholesterol metabolism on total plasma cholesterol, HDL-C and LDL-C in the mouse. (C) 2011 Elsevier B.V. All rights reserved.
引用
收藏
页码:333 / 342
页数:10
相关论文
共 50 条
  • [1] A physiologically based in silico kinetic model predicting plasma cholesterol concentrations in humans
    van de Pas, Niek C. A.
    Woutersen, Ruud A.
    van Ommen, Ben
    Rietjens, Ivonne M. C. M.
    de Graaf, Albert A.
    JOURNAL OF LIPID RESEARCH, 2012, 53 (12) : 2734 - 2746
  • [2] Application of a physiologically-based pharmacokinetic model for the prediction of bumetanide plasma and brain concentrations in the neonate
    Donovan, Maria D.
    Abduljalil, Khaled
    Cryan, John F.
    Boylan, Geraldine B.
    Griffin, Brendan T.
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2018, 39 (03) : 125 - 134
  • [3] A PHYSIOLOGICALLY-BASED PHARMACOKINETIC (PBPK) MODEL FOR PREDICTION OF PLASMA AND LUNG CONCENTRATIONS AFTER ADMINISTRATION OF CEFTAZIDIME.
    Zhou, D.
    Li, J.
    Xu, H.
    Al-Huniti, N.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2015, 97 : S88 - S88
  • [4] Predicting individual responses to pravastatin using a physiologically based kinetic model for plasma cholesterol concentrations
    van de Pas, Niek C. A.
    Rullmann, Johan A. C.
    Woutersen, Ruud A.
    van Ommen, Ben
    Rietjens, Ivonne M. C. M.
    de Graaf, Albert A.
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2014, 41 (04) : 351 - 362
  • [5] Predicting individual responses to pravastatin using a physiologically based kinetic model for plasma cholesterol concentrations
    Niek C. A. van de Pas
    Johan A. C. Rullmann
    Ruud A. Woutersen
    Ben van Ommen
    Ivonne M. C. M. Rietjens
    Albert A. de Graaf
    Journal of Pharmacokinetics and Pharmacodynamics, 2014, 41 : 351 - 362
  • [6] A PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODEL OF ETHANOL IN THE MOUSE
    PASTINO, GM
    SULTATOS, LG
    FLYNN, EJ
    FASEB JOURNAL, 1994, 8 (05): : A952 - A952
  • [7] Physiologically-based pharmacokinetic model for predicting blood and tissue concentrations
    Zhu, Leo
    Pei, William
    DiCiano, Patricia
    Brands, Bruna
    Wickens, Christine M.
    Le Foll, Bernard
    Kwong, Bronsen
    Parashar, Megha
    Sivananthan, Atchu
    Mahadevan, Radhakrishnan
    COMPUTERS & CHEMICAL ENGINEERING, 2021, 154
  • [8] PREDICTION OF ANTICHOLINESTERASE ACTIVITY AND URINARY METABOLITES OF ISOFENPHOS - USE OF A PERCUTANEOUS PHYSIOLOGICALLY-BASED PHARMACOKINETIC PHYSIOLOGICALLY-BASED PHARMACODYNAMIC MODEL
    KNAAK, JB
    ALBAYATI, MA
    RAABE, OG
    BLANCATO, JN
    BIOMARKERS OF HUMAN EXPOSURE TO PESTICIDES, 1994, 542 : 284 - 300
  • [9] Estimation of background exposure to toluene using a physiologically-based kinetic model
    Pierce, CH
    Dills, RL
    Lewandowski, TA
    Morgan, MS
    Wessels, MA
    Shen, DD
    Kalman, DA
    JOURNAL OF OCCUPATIONAL HEALTH, 1997, 39 (02) : 130 - 137
  • [10] Development of a physiologically-based pharmacokinetic pediatric brain model for prediction of cerebrospinal fluid drug concentrations and the influence of meningitis
    Verscheijden, Laurens F. M.
    Koenderink, Jan B.
    de Wildt, Saskia N.
    Russel, Frans G. M.
    PLOS COMPUTATIONAL BIOLOGY, 2019, 15 (06)